跳至主要内容
临床试验/CTRI/2025/08/093364
CTRI/2025/08/093364尚未招募3 期

Evaluating The Effectiveness Of Individualized Homoeopathic Medicines VS Thyroidinum 3X In Treatment Of Sub-Clinical Hypothyroidism: An Open Label Randomized Control Clinical Trial

Dr Honey1 个研究点 分布在 1 个国家目标入组 60 人开始时间: 2025年9月1日最近更新:

试验速览

阶段
3 期
状态
尚未招募
发起方
入组人数
60
试验地点
1
主要终点
Comparison of Effectiveness: The trial is expected to reveal individualized homoeopathic

研究概览

简要总结

This study evaluating the effectiveness of Individualized homoeopathic medicines and Thyroidinum 3X in treating the patients of Sub-Clinical Hypothyroidism.

aged 18-60 years. Patients will be randomly assigned through online software to receive either individualized

homoeopathic medicines or Thyroidinum 3X. The study

will measure the improvement by investigating biochemically using S.TSH levels. It is expected that there will be clinically symptomatic improvement assess through modified naranjo criteria along with general well-being, without any substantial medicinal adverse effects. The results will provide valuable insights into the effectiveness of homoeopathic approaches in treatment of Sub-Clinical Hypothyroidism.

研究设计

研究类型
Interventional
分配方式
Randomized
盲法
None

入排标准

年龄范围
18.00 Year(s) 至 60.00 Year(s)(—)
性别
All

入选标准

  • Both sexes of age group above 18 years and below 60 years
  • Patients with newly diagnosed sub clinical hypothyroidism (elevated TSH levels but T3 and T4 are within normal limit) with or without anti TPO antibody.

排除标准

  • Sub-clinical hypothyroidism patient’s sufferings from any life-threatening illness, mental illness who are terminally ill, under immunosuppressive treatment or self-reported immune-compromised state.
  • Patients of malignancy or too sick for consultation.
  • Patient on substance abuse.
  • (Drugs/Alcohol/Smoking).
  • Females who are in pregnancy and lactating period.

结局指标

主要结局

Comparison of Effectiveness: The trial is expected to reveal individualized homoeopathic

时间窗: 11 months

medicines (GROUP A) yield a significant reduction in serum TSH levels. This outcome would support

时间窗: 11 months

the hypothesis that homoeopathic interventions may effectively in sub clinical hypothyroidism.

时间窗: 11 months

次要结局

  • It is expected that T3 and T4 levels will remain within their normal reference range and(Anti TPO antibody levels will also starts moving towards the normal reference range.)
  • This study expected to identify the most effective homoeopathic medicines for the management of(subclinical hypothyroidism.)
  • It is expected that there will be symptomatic improvement assess through modified naranjo(criteria along with general well-being, without any substantial medicinal adverse effects.)

研究者

发起方
Dr Honey
申办方类型
Other [self]
责任方
Principal Investigator
主要研究者

Dr Honey

Dr B R Sur Homoeopathic Medical College,Hospital And Research Centre

研究点 (1)

Loading locations...

相似试验